Home
Resources
Diseases
Compendium
Training
Evaluation
The Tool
The Tutorial
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Type of publications
Guidelines (30)
NITAG documentation (1591)
Reports (55)
SAGE documentation (218)
Scientific publications (112)
Systematic reviews (SYSVAC) (2750)
Regions
Africa (267)
Americas (762)
Eastern Mediterranean (48)
Europe (704)
South-East Asia (78)
Western Pacific (196)
Diseases
Chikungunya (9)
Cholera (33)
COVID-19 (1481)
Cytomegalovirus (1)
Dengue (39)
Diphtheria (79)
Ebola (16)
Escherichia coli (ETEC) (2)
Haemophilus influenzae type B (66)
Hepatitis A (63)
Hepatitis B (153)
Hepatitis C (4)
Hepatitis E (5)
Herpes simplex (1)
Herpes zoster (66)
HIV / AIDS (10)
Human papillomavirus (HPV) (472)
Influenza (573)
Japanese encephalitis (34)
Lyme disease, Borreliosis (1)
Malaria (27)
Measles (128)
Meningococcal disease (145)
Mpox (55)
Mumps (46)
Pertussis (104)
Pneumococcal disease (266)
Poliomyelitis (84)
Q fever (1)
Rabies (28)
Rotavirus (115)
RSV (Respiratory syncytial virus) (47)
Rubella (64)
Salmonella (2)
Shigella (1)
Smallpox (16)
Streptococcus group B (6)
Tetanus (59)
Tick-borne encephalitis (12)
Tuberculosis (73)
Typhoid (23)
Varicella (69)
Yellow fever (42)
Zika (1)
Show more
4756 results found
2021
∙
UNITAG
Recommendation Report: The Use of the Inactivated SARS-CoV-2 BBIBP-CORV-CorV Sinopharm Vaccine
2021
∙
UNITAG
Recommendation Report: The Use of the mRNA Moderna Vaccine in Uganda
2021
∙
Conseil Supérieur de la Santé (CSS)
Recommendations for the administration of one or two doses of mRNA vaccines in people who are or have been infected with SARS-CoV-2 in Belgium - 09 June 2021
2021
∙
NIAC
RECOMMENDATIONS FOR THE ROLE OF COVID-19 HETEROLOGOUS VACCINATION IN THE NATIONAL PROGRAMME
2021
∙
Conseil Supérieur de la Santé (CSS)
Recommendations for the vaccination of children at increased risk of invasive pneumococcal disease (PID)
2021
∙
Folkhälsomyndigheten
Recommendations for vaccination against covid-19 in Sweden
2021
∙
NACI, Public Health Agency of Canada
Recommendations on the use of COVID-19 Vaccines
2021
∙
NACI
Recommendations on the use of COVID-19 Vaccines
2021
∙
CCVS
Recommendations on the use of the new oral vaccine nOPV2 in the outbreak response caused by vaccine-derived poliovirus type 2
2021
∙
Conseil Supérieur de la Santé (CSS)
Recommendations regarding the pediatric vaccination against SARS-CoV-2 of children aged older than 12 in Belgium
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register